Senores Pharmaceuticals Limited (NSEI: SENORES)
Health Care · Pharmaceuticals · IN
Rs1,320.00
-2.19% today · +84.0% 1Y
Senores Pharmaceuticals Limited (NSEI: SENORES) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $628.13M and employs 368 people.
Over the last twelve months the share price has gained 84.0%, trading between 705.10 and 1.60K.
Tweenvest scores Senores Pharmaceuticals Limited across four factors: quality 60/100, value 23/100. Its strongest factor is quality.
SENORES price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $628.13M
- Revenue (TTM)
- $71.95M
- P/E
- 46.65
- EPS
- 28.30
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- Rs1,599.00
- 52-week low
- Rs705.10
- Avg volume (3M)
- —
- Shares outstanding
- 46.05M
- Employees
- 368
- Next earnings
- —
About Senores Pharmaceuticals Limited
Established in 2017 and headquartered in Ahmedabad, India, Senores Pharmaceuticals Ltd. is actively involved in the development, manufacturing, and global commercialization of pharmaceutical and related products. Its extensive portfolio reaches markets across India, the United States, the United Kingdom, Canada, and other international territories. The company specializes in a diverse array of therapeutic solutions, encompassing analgesics/antipyretics, anesthetics, antibacterials, antivirals, antifungals, antioxidants, antineoplastics, blood-related therapies, cardiovascular and neurological medications, antacids, and vitamin and mineral supplements. Additionally, Senores offers a selection of generic drugs targeting pain, inflammation, fever, diabetes, malaria, and urinary tract conditions, as well as neutral supplements. Complementing its product offerings, the firm also provides management and consultancy services.
- ISIN
- INE0RB801010
- Founded
- 2017
- Listed since
- Dec 30, 2024
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shandong Wohua Pharmaceutical Co., Ltd.SZSE: 002107 | $633.39M | CN¥7.35 | +3.67% |
| Jianmin Pharmaceutical Group Co.,Ltd.SHSE: 600976 | $630.03M | CN¥27.51 | +2.42% |
| Newland Pharmaceutical Co., Ltd.SZSE: 301277 | $629.84M | CN¥10.76 | +2.77% |
| TTY Biopharm Company LimitedTPEX: 4105 | $629.11M | NT$80.90 | +2.53% |
| Wuhan Hvsen Biotechnology Co.,Ltd.SZSE: 300871 | $625.65M | CN¥20.91 | -0.90% |
| Henan Taloph Pharmaceutical Stock Co.,LtdSHSE: 600222 | $625.37M | CN¥7.78 | -1.39% |
| Shanghai New World Co., LtdSHSE: 600628 | $623.88M | CN¥6.46 | +1.57% |
| Sun Pharma Advanced Research Company LimitedNSEI: SPARC | $622.35M | Rs185.60 | -1.14% |
Figures last refreshed Oct 11, 2026.